myeloproliferative disorders的意思|示意
骨髓增殖性疾病
myeloproliferative disorders的网络常见释义
骨髓增生性疾病 骨髓增生性疾病(Myeloproliferative disorders,MPDs)是指 骨髓组织持续增殖而引起的一..
骨髓增殖性疾病 2）骨髓增殖性疾病（myeloproliferative disorders，MPD）：包括真性红细胞增多症、原发性血小板增多症和骨髓纤维化症。
骨髓增生异常 ▇ 骨髓增生异常（Myeloproliferative Disorders） 数个研究团体已经在polycythemia vera，essential thrombocythemia及idiopathic myelofibrosis发现了JAK2后天的突变。
髓系增殖性疾病 ...网 粒细胞白血病（chronic myeloid 1eukemia，CML）011，而RARa一儿历TM则表现为髓系增殖性疾病（myeloproliferative disorders，MPD）。3。
myeloproliferative disorders相关短语
1、 chronic myeloproliferative disorders 慢性骨髓增殖性疾病 ; 性疾病
2、 Cancer Research - Myeloproliferative disorders 癌症研究
myeloproliferative disorders相关例句
Chronic myelocytic leukemia is a clonal proliferation of hematopoietic stem cells caused by myeloproliferative disorders.
慢性粒细胞白血病是一种造血干细胞克隆性增殖所致的骨髓增殖性疾病。
Conditions included myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, and bronchial carcinoma.
疾病可引发脊髓发育不良、脊髓增殖失调，急性髓性白血病和支气管瘤。
There is high frequency of JAK2 V617F mutation in myeloproliferative disorders and it could be used as the diagnostic marker for myeloproliferative disorders.
JAK2基因V617F突变在骨髓增殖性疾病中有较高的检出率，可作为骨髓增殖性疾病特异性诊断指标。
So SHP-2 could be the key element of the high value-added signal-regulated in myeloid cells and a important regulatory in the pathogenesis of myeloproliferative disorders.
因此，SHP-2可能是髓系细胞高增殖性信号调控的关键分子，及髓系增殖性疾病的发病机制中重要的调控分子之一。
It has been reported in association with acute myeloid leukemia, myeloproliferative disorders, and myelodysplasia in blast transformation, as well as in patients with no known hematological disorders.
它曾被报告与淋巴母细胞转变相关的急性骨髓性白血病、骨髓增生性疾病、脊髓发育不全症等等，甚至于那些不具已知的血液学异常相关的病人们身上。